Results 21 to 30 of about 753,139 (314)

Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans

open access: yesArthritis & Rheumatology, 2021
The optimal time to start biologics in polyarticular juvenile idiopathic arthritis (JIA) remains uncertain. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) developed 3 consensus treatment plans (CTPs) for untreated polyarticular JIA to
Y. Kimura   +11 more
semanticscholar   +1 more source

Risk Factors for the Development of Low Quality of Life in Adults with Juvenile Idiopathic Arthritis

open access: yesGalician Medical Journal, 2018
Juvenile idiopathic arthritis is known to persist into adulthood which is associated with the development of a large number of long-term consequences, including low quality of life.
Marta Dzhus
doaj   +1 more source

Classifications and imaging of juvenile spondyloarthritis

open access: yesJournal of Ultrasonography, 2018
Juvenile spondyloarthritis may be present in at least 3 subtypes of juvenile idiopathic arthritis according to the classification of the International League of Associations for Rheumatology.
Iwona Sudoł-Szopińska   +5 more
doaj   +1 more source

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodology

open access: yesRheumatology International, 2018
The aim of this project was to cross-culturally adapt and validate the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) questionnaire in 54 languages across 52 different countries that are members of the Paediatric Rheumatology International
F. Bovis   +10 more
semanticscholar   +1 more source

Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study

open access: yesHealth Technology Assessment, 2020
Background: In the UK, juvenile idiopathic arthritis is the most common inflammatory disorder in childhood, affecting 10 : 100,000 children and young people aged
Ashley P Jones   +15 more
doaj   +1 more source

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis

open access: yesAnnals of the Rheumatic Diseases, 2017
Objectives To assess if the Juvenile Arthritis Disease Activity Score (JADAS71) could be used to correctly identify patients with juvenile idiopathic arthritis (JIA) in need of antitumour necrosis factor therapy (anti-TNF) therapy 3 and 6 months after ...
J. Swart   +3 more
semanticscholar   +1 more source

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

open access: yesPediatric Rheumatology Online Journal, 2010
Recently, the Food and Drug Administration placed a "black box" label on etanercept, and other tumor necrosis factor inhibitors used to treat childhood arthritis, warning of the risk of malignancies.
Cron Randy Q, Beukelman Timothy
doaj   +1 more source

Systemic-onset juvenile idiopathic arthritis

open access: yesDefinitions, 2020
NATURE REVIEWS | DRUG DISCOVERY www.nature.com/reviews/drugdisc Supplementary table S1 | Broad Spectrum of Diseases Responsive to Anakinra Disease Condition References Joint, Bone and Muscle Diseases rheumatoid arthritis 1-21 psoriatic arthritis 22,23 ...

semanticscholar   +1 more source

Juvenile idiopathic arthritis

open access: yesContemporary Clinical Dentistry, 2014
Juvenile Idiopathic Arthritis (JIA) is the most chronic musculoskeletal disease of pediatric population. The chronic course of disease has a great impact on oral health. Temporomandibular joint is involved in JIA causing limited mouth opening with progressive open bite, retrognathia, microgenia and bird like appearance.
Krupa H Bhatt   +3 more
openaire   +3 more sources

Long‐Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow‐Up in the Population‐Based Nordic Juvenile Idiopathic Arthritis Cohort

open access: yesArthritis care & research, 2020
The present study was undertaken to assess the long‐term course, remission rate, and disease burden in juvenile idiopathic arthritis (JIA) 18 years after disease onset in a population‐based setting from the early biologic era.
M. Glerup   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy